From: Overview of technical solutions and assessment of clinical usefulness of capsule endoscopy
Publication | Number of diagnosed cases | Type of disease | Results |
---|---|---|---|
Laurain A. [82] | 80 | Recurrent oesophageal varices | Capsule adequately classified 77.5Â % of the patients for prophylaxis indication |
Jeon S. [83] | 2879 | Cirrhosis patients with portal hypertension | The prevalence of PHE was 40Â %. Comparing the PHE and non-PHE groups, the most common findings were angiodysplasias in 55.7Â % and varices in 38.9Â %. Active bleeding was observed in 16.6 and 3.7Â %, respectively |
Farnbacher M. [84] | 65 | Colorectal polyps | At a 30 % QV (QuickView) setting, the QV video presented 89 % of the significant polyps and 86 % of any polyps with ≥1 frame (per-polyp analysis) identified in NM before. At a 10 % QV setting, 98 % of the 52 patients with significant polyps could be identified (per-patient analysis) by QV video analysis |
Ou G. [85] | 6 | Impact of chewing gum | Chewing gum did not have any significant effect on gastric transit time (rate ratio 1.06; p = 0.75), small-bowel transit time (rate ratio 0.91; p = 0.65), or completion rate of capsule endoscopies |
Triantafyllou K. [86] | 75 | Complementing incomplete colonoscopy | One-third of the patients underwent capsule endoscopies immediately after colonoscopy |
Oliva S. [87] | 198 | Small bowel cleansing by capsule endoscopy addressed in children | It supported the use of 25Â ml/kg of polyethylene glycol solution plus 20Â ml (376Â mg) of oral simethicone as the preparation of choice for capsule endoscopy |